Takeda Failed To Warn Of Actos Cancer Risk, Jury Hears

Law360, Los Angeles (February 28, 2013, 7:45 PM EST) -- Japan's Takeda Pharmaceutical Co. should have added a bladder cancer warning to its diabetes drug Actos long before a man now dying of the disease began taking the medication, his attorney told a Los Angeles jury Thursday in the first product liability trial of its kind.

Bladder cancer showed up in rats dosed with Actos even before the U.S. Food and Drug Administration approved the drug in 1999, and studies released in 2005 documented the increased risk to humans, attorney Michael Miller of The Miller Firm...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.